Table 1.
Association Between LINC00963 Expression and Clinicopathological Factors in Ovarian Cancer Patients
| Variable | High Expression (n=21) | Low Expression(n=14) | P-value |
|---|---|---|---|
| Age (years) | |||
| <50 | 12 | 7 | |
| ≥50 | 9 | 7 | 0.7391 |
| Histological Subtype | |||
| Serous | 14 | 8 | |
| Others | 7 | 6 | 0.7241 |
| FIGO Stage | |||
| I–II | 2 | 6 | |
| III–IV | 19 | 8 | 0.0386 |
| Residual Tumor Diameter (cm) | |||
| <1 | 8 | 8 | |
| ≥1 | 13 | 6 | 0.3167 |
| Lymph Node Metastasis | |||
| Yes | 16 | 5 | |
| No | 5 | 9 | 0.0332 |
Notes: Total data from 35 tumor tissues of ovarian cancer patients were analyzed. For the expression of LINC00963 was assayed by qRT-PCR. Data were analyzed by chi-squared test and Fisher’s exact test. P-value in bold indicates statistically significant.